Renaissance Technologies (RenTech)'s MXCT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 1.99 M shares of MaxCyte, Inc. (MXCT) worth $1.4 M, representing 0.00% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in MXCT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 1.21 M shares. Largest reduction occurred in Q1 2024, reducing 26,500 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s MaxCyte (MXCT) Holding Value Over Time
Track share changes against reported price movement
Quarterly MaxCyte (MXCT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1.21 M | Add 153.30% | 1.99 M | $0.70 |
| Q4 2025 | +36,124 | Add 4.81% | 786,900 | $1.55 |
| Q3 2025 | +32,976 | Add 4.59% | 750,776 | $1.58 |
| Q2 2025 | +349,900 | Add 95.11% | 717,800 | $2.18 |
| Q1 2025 | +86,700 | Add 30.83% | 367,900 | $2.73 |
| Q4 2024 | +91,100 | Add 47.92% | 281,200 | $4.16 |
| Q3 2024 | -20,814 | Reduce 9.87% | 190,100 | $3.89 |
| Q2 2024 | +48,314 | Add 29.71% | 210,914 | $3.92 |
| Q1 2024 | -26,500 | Reduce 14.01% | 162,600 | $4.19 |
| Q4 2023 | -22,000 | Reduce 10.42% | 189,100 | $4.70 |
| Q3 2023 | +135,400 | Add 178.86% | 211,100 | $3.12 |
| Q2 2023 | -25,500 | Reduce 25.20% | 75,700 | $0.00 |
| Q1 2023 | +101,200 | New Buy | 101,200 | $0.00 |
Renaissance Technologies (RenTech)'s MaxCyte Investment FAQs
Renaissance Technologies (RenTech) first purchased MaxCyte, Inc. (MXCT) in Q1 2023, acquiring 101,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held MaxCyte, Inc. (MXCT) for 13 quarters since Q1 2023.
Renaissance Technologies (RenTech)'s largest addition to MaxCyte, Inc. (MXCT) was in Q1 2026, adding 1,993,200 shares worth $1.4 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 1,993,200 shares of MaxCyte, Inc. (MXCT), valued at approximately $1.4 M.
As of the Q1 2026 filing, MaxCyte, Inc. (MXCT) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in MaxCyte, Inc. (MXCT) was 1,993,200 shares, as reported at the end of Q1 2026.